MedTrace Logo

C-Cure Clinical Trial

NCT00810238 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2012-09-05

No results posted yet for this study

Summary

The purpose of this clinical trial is to evaluate the feasibility, safety and efficacy of left ventricular endocardial injection of guided bone marrow-derived cardiopoietic cells (C-Cure) in the setting of chronic heart failure secondary to ischemic cardiomyopathy.

Conditions

  • Heart Failure Class II or III

Interventions

BIOLOGICAL

C-Cure

Intraventricular injection

Sponsors & Collaborators

  • Celyad Oncology SA

    lead INDUSTRY

Principal Investigators

  • Jozef Bartunek, MD, PhD · VZW Cardiovascular Research Center Aalst

  • André Terzic, MD, PhD · Mayo Clinic, Rochester, USA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2010-07-31
Completion
2012-01-31

Countries

  • Belgium
  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00810238 on ClinicalTrials.gov